Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Market Size Breakdown by Segment
1.5.1 Market Segmentation by Product
1.5.2 Market Segmentation by Endoscope Type
1.5.3 Market Segmentation by End User
1.5.4 Market Segmentation by Region
1.6 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 P&S Intelligence Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Designation
2.2.4 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 High-level disinfectants & test strips
4.1.1.2 Detergents & wipes
4.1.1.3 AERs
4.1.1.4 Endoscope drying, storage, & transportation systems
4.1.1.5 Endoscope tracking solutions
4.1.1.6 Others
4.1.2 By Endoscope Type
4.1.2.1 Flexible
4.1.2.1.1 Upper GI endoscopes
4.1.2.1.2 Colonoscopes
4.1.2.1.3 Bronchoscopes
4.1.2.1.4 Sigmoidoscopes
4.1.2.1.5 Laryngoscopes
4.1.2.1.6 Duodenoscopes
4.1.2.1.7 Nasopharyngoscopes
4.1.2.1.8 Rhinoscopes
4.1.2.1.9 Others
4.1.2.2 Rigid
4.1.2.2.1 Laparoscopes
4.1.2.2.2 Ureteroscopes
4.1.2.2.3 Gynecologic endoscopes
4.1.2.2.4 Arthroscopes
4.1.2.2.5 Cystoscopes
4.1.2.2.6 Neuroendoscopes
4.1.3 By End User
4.1.3.1 Hospitals
4.1.3.2 ASCs and clinics
4.1.3.3 Others
Chapter 5. Industry Outlook
5.1 Market Dynamics
5.1.1 Trends
5.1.1.1 Increasing adoption of comprehensive contracts
5.1.1.2 Rising number of partnerships & product launches
5.1.2 Drivers
5.1.2.1 Supportive regulatory guidelines that promote endoscopic reprocessing
5.1.2.2 Increasing cases of diseases that require endoscopy procedures
5.1.2.3 Technological advances in endoscope reprocessing methods
5.1.2.4 Growing risks of developing endoscope-related infections
5.1.3 Restraints
5.1.3.1 High cost of endoscopic reprocessing equipment
5.1.3.2 Growth in popularity of single-use endoscopes
5.2 Impact of COVID-19
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Buyers
5.3.2 Bargaining Power of Suppliers
5.3.3 Intensity of Rivalry
5.3.4 Threat of New Entrants
5.3.5 Threat of Substitutes
Chapter 6. Global Market Size and Forecast
6.1 By Product
6.2 By Endoscope Type
6.2.1 Flexible Endoscope Reprocessing Market, by Endoscope Type
6.2.2 Rigid Endoscope Reprocessing Market, by Endoscope Type
6.3 By End User
6.4 By Region
Chapter 7. North America Market Size and Forecast
7.1 By Product
7.2 By Endoscope Type
7.2.1 Flexible Endoscope Reprocessing Market, by Endoscope Type
7.2.2 Rigid Endoscope Reprocessing Market, by Endoscope Type
7.3 By End User
7.4 By Country
Chapter 8. Europe Market Size and Forecast
8.1 By Product
8.2 By Endoscope Type
8.2.1 Flexible Endoscope Reprocessing Market, by Endoscope Type
8.2.2 Rigid Endoscope Reprocessing Market, by Endoscope Type
8.3 By End User
8.4 By Country
Chapter 9. APAC Market Size and Forecast
9.1 By Product
9.2 By Endoscope Type
9.2.1 Flexible Endoscope Reprocessing Market, by Endoscope Type
9.2.2 Rigid Endoscope Reprocessing Market, by Endoscope Type
9.3 By End User
9.4 By Country
Chapter 10. LATAM Market Size and Forecast
10.1 By Product
10.2 By Endoscope Type
10.2.1 Flexible Endoscope Reprocessing Market, by Endoscope Type
10.2.2 Rigid Endoscope Reprocessing Market, by Endoscope Type
10.3 By End User
10.4 By Country
Chapter 11. MEA Market Size and Forecast
11.1 By Product
11.2 By Endoscope Type
11.2.1 Flexible Endoscope Reprocessing Market, by Endoscope Type
11.2.2 Rigid Endoscope Reprocessing Market, by Endoscope Type
11.3 By End User
11.4 By Country
Chapter 12. Competitive Landscape
12.1 List of Players and Their Offerings
12.2 Comparison of Key Players
Chapter 13. Company Profiles
13.1 Advanced Sterilization Products Inc.
13.1.1 Business Overview
13.1.2 Product and Service Offerings
13.2 ARC Group of Companies Inc.
13.2.1 Business Overview
13.2.2 Product and Service Offerings
13.3 BES Healthcare Ltd.
13.3.1 Business Overview
13.3.2 Product and Service Offerings
13.4 CONMED Corporation
13.4.1 Business Overview
13.4.2 Product and Service Offerings
13.4.3 Key Financial Summary
13.5 Getinge AB
13.5.1 Business Overview
13.5.2 Product and Service Offerings
13.5.3 Key Financial Summary
13.5.4 Strategic Developments
13.6 Borer Chemie AG
13.6.1 Business Overview
13.6.2 Product and Service Offerings
13.7 Metrex Research LLC
13.7.1 Business Overview
13.7.2 Product and Service Offerings
13.8 Belimed AG
13.8.1 Business Overview
13.8.2 Product and Service Offerings
13.9 MDG Engineering S.r.l.
13.9.1 Business Overview
13.9.2 Product and Service Offerings
13.9.3 Strategic Developments
13.10 Medalkan TECHNIKI EMPORIKI STAVRIDIS LTD.
13.10.1 Business Overview
13.10.2 Product and Service Offerings
13.10.3 Strategic Developments
13.11 Medonica Co. LTD.
13.11.1 Business Overview
13.11.2 Product and Service Offerings
13.12 Tuttnauer
13.12.1 Business Overview
13.12.2 Product and Service Offerings
13.13 HOYA Corporation
13.13.1 Business Overview
13.13.2 Product and Service Offerings
13.13.3 Key Financial Summary
13.13.4 Strategic Development
13.14 Olympus Corporation
13.14.1 Business Overview
13.14.2 Product & Service Offerings
13.14.3 Key Financial Summary
13.14.4 Strategic development
13.15 STERIS plc
13.15.1 Business Overview
13.15.2 Product and Service Offerings
13.15.3 Key Financial Summary
13.15.4 Strategic Development
13.16 Ecolab Inc.
13.16.1 Business Overview
13.16.2 Product and Service Offerings
13.16.3 Key Financial Summary
13.16.4 Strategic Development
13.17 Richard Wolf GmbH
13.17.1 Business Overview
13.17.2 Product and Service Offerings
13.18 Creo Medical Group PLC
13.18.1 Business Overview
13.18.2 Product and Service Offerings
13.18.3 Key Financial Summary
13.18.4 Strategic Developments
13.19 Micro-Scientific LLC
13.19.1 Business Overview
13.19.2 Product and Service Offerings
13.20 Summit Imaging Inc.
13.20.1 Business Overview
13.20.2 Product and Service Offerings
13.21 SHINVA MEDICAL INSTRUMENT CO. LTD.
13.21.1 Business Overview
13.21.2 Product and Service Offerings
Chapter 14. Appendix
14.1 Sources and References
14.2 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2022)
TABLE 3 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2023–2027)
TABLE 4 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2028–2030)
TABLE 5 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 6 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 7 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 8 GLOBAL FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 9 GLOBAL FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 10 GLOBAL FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 11 GLOBAL RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 12 GLOBAL RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 13 GLOBAL RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 14 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2022)
TABLE 15 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2023–2027)
TABLE 16 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2028–2030)
TABLE 17 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY REGION, $M (2017–2022)
TABLE 18 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY REGION, $M (2023–2027)
TABLE 19 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY REGION, $M (2028–2030)
TABLE 20 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2022)
TABLE 21 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2023–2027)
TABLE 22 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2028–2030)
TABLE 23 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 24 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 25 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 26 NORTH AMERICA FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 27 NORTH AMERICA FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 28 NORTH AMERICA FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 29 NORTH AMERICA RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 30 NORTH AMERICA RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 31 NORTH AMERICA RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 32 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2022)
TABLE 33 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2023–2027)
TABLE 34 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2028–2030)
TABLE 35 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2022)
TABLE 36 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2023–2027)
TABLE 37 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2028–2030)
TABLE 38 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2022)
TABLE 39 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2023–2027)
TABLE 40 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2028–2030)
TABLE 41 EUROPE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 42 EUROPE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 43 EUROPE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 44 EUROPE FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 45 EUROPE FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 46 EUROPE FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 47 EUROPE RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 48 EUROPE RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 49 EUROPE RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 50 EUROPE ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2022)
TABLE 51 EUROPE ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2023–2027)
TABLE 52 EUROPE ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2028–2030)
TABLE 53 EUROPE ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2022)
TABLE 54 EUROPE ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2023–2027)
TABLE 55 EUROPE ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2028–2030)
TABLE 56 APAC ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2022)
TABLE 57 APAC ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2023–2027)
TABLE 58 APAC ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2028–2030)
TABLE 59 APAC ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 60 APAC ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 61 APAC ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 62 APAC FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 63 APAC FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 64 APAC FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 65 APAC RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 66 APAC RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 67 APAC RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 68 APAC ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2022)
TABLE 69 APAC ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2023–2027)
TABLE 70 APAC ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2028–2030)
TABLE 71 APAC ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2022)
TABLE 72 APAC ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2023–2027)
TABLE 73 APAC ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2028–2030)
TABLE 74 LATAM ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2022)
TABLE 75 LATAM ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2023–2027)
TABLE 76 LATAM ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2028–2030)
TABLE 77 LATAM ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 78 LATAM ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 79 LATAM ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 80 LATAM FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 81 LATAM FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 82 LATAM FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 83 LATAM RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 84 LATAM RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 85 LATAM RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 86 LATAM ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2022)
TABLE 87 LATAM ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2023–2027)
TABLE 88 LATAM ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2028–2030)
TABLE 89 LATAM ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2022)
TABLE 90 LATAM ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2023–2027)
TABLE 91 LATAM ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2028–2030)
TABLE 92 MEA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2022)
TABLE 93 MEA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2023–2027)
TABLE 94 MEA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2028–2030)
TABLE 95 MEA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 96 MEA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 97 MEA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 98 MEA FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 99 MEA FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 100 MEA FLEXIBLE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 101 MEA RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2022)
TABLE 102 MEA RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2023–2027)
TABLE 103 MEA RIGID ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2028–2030)
TABLE 104 MEA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2022)
TABLE 105 MEA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2023–2027)
TABLE 106 MEA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2028–2030)
TABLE 107 MEA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2022)
TABLE 108 MEA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2023–2027)
TABLE 109 MEA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2028–2030)
TABLE 110 LIST OF PLAYERS AND THEIR OFFERINGS
TABLE 111 COMPARISON OF KEY PLAYERS (2021)
TABLE 110 ADVANCED STERILIZATION PRODUCTS INC. – AT A GLANCE
TABLE 111 ARC GROUP OF COMPANIES INC. – AT A GLANCE
TABLE 112 BES HEALTHCARE LTD. – AT A GLANCE
TABLE 113 CONMED CORPORATION – AT A GLANCE
TABLE 114 CONMED CORPORATION – KEY FINANCIAL SUMMARY
TABLE 115 GETINGE AB – AT A GLANCE
TABLE 116 GETINGE AB – KEY FINANCIAL SUMMARY
TABLE 117 BORER CHEMIE AG – AT A GLANCE
TABLE 118 METREX RESEARCH LLC – AT A GLANCE
TABLE 119 BELIMED AG – AT A GLANCE
TABLE 120 MDG ENGINEERING S.R.L. – AT A GLANCE
TABLE 121 MEDALKAN TECHNIKI EMPORIKI STAVRIDIS LTD. – AT A GLANCE
TABLE 122 MEDONICA CO. LTD. – AT A GLANCE
TABLE 123 TUTTNAUER – AT A GLANCE
TABLE 124 HOYA CORPORATION – AT A GLANCE
TABLE 125 HOYA CORPORATION – KEY FINANCIAL SUMMARY
TABLE 126 OLYMPUS CORPORATION – AT A GLANCE
TABLE 127 OLYMPUS CORPORATION – KEY FINANCIAL SUMMARY
TABLE 128 STERIS PLC – AT A GLANCE
TABLE 129 STERIS PLC – KEY FINANCIAL SUMMARY
TABLE 130 ECOLAB INC. – AT A GLANCE
TABLE 131 ECOLAB INC. – KEY FINANCIAL SUMMARY
TABLE 132 RICHARD WOLF GMBH – AT A GLANCE
TABLE 133 CREO MEDICAL GROUP PLC – AT A GLANCE
TABLE 134 CREO MEDICAL GROUP PLC – KEY FINANCIAL SUMMARY
TABLE 135 MICRO-SCIENTIFIC LLC – AT A GLANCE
TABLE 136 SUMMIT IMAGING INC. – AT A GLANCE
TABLE 137 SHINVA MEDICAL INSTRUMENT CO. LTD. – AT A GLANCE
LIST OF FIGURES
FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 6 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 CURRENCY CONVERSION RATES FOR USD (2022)
FIG 9 GLOBAL ENDOSCOPE REPROCESSING MARKET
FIG 10 BARGAINING POWER OF BUYERS
FIG 11 BARGAINING POWER OF SUPPLIERS
FIG 12 INTENSITY OF RIVALRY
FIG 13 THREAT OF NEW ENTRANTS
FIG 14 THREAT OF SUBSTITUTES
FIG 15 GLOBAL ENDOSCOPE REPROCESSING MARKET SNAPSHOT
FIG 16 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2030)
FIG 17 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2030)
FIG 18 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2030)
FIG 19 GLOBAL ENDOSCOPE REPROCESSING MARKET, BY REGION, $M (2017–2030)
FIG 20 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SNAPSHOT
FIG 21 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2030)
FIG 22 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2030)
FIG 23 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2030)
FIG 24 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2030)
FIG 25 EUROPE ENDOSCOPE REPROCESSING MARKET SNAPSHOT
FIG 26 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2030)
FIG 27 EUROPE ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2030)
FIG 28 EUROPE ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2030)
FIG 29 EUROPE ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2030)
FIG 30 APAC ENDOSCOPE REPROCESSING MARKET SNAPSHOT
FIG 31 APAC ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2030)
FIG 32 APAC ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2030)
FIG 33 APAC ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2030)
FIG 34 APAC ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2030)
FIG 35 LATAM ENDOSCOPE REPROCESSING MARKET SNAPSHOT
FIG 36 LATAM ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2030)
FIG 37 LATAM ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2030)
FIG 38 LATAM ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2030)
FIG 39 LATAM ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2030)
FIG 40 MEA ENDOSCOPE REPROCESSING MARKET SNAPSHOT
FIG 41 MEA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, $M (2017–2030)
FIG 42 MEA ENDOSCOPE REPROCESSING MARKET, BY ENDOSCOPE TYPE, $M (2017–2030)
FIG 43 MEA ENDOSCOPE REPROCESSING MARKET, BY END USER, $M (2017–2030)
FIG 44 MEA ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, $M (2017–2030)
FIG 45 CONMED CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 46 GETINGE AB – REVENUE SPLIT BY BUSINESS AREA AND GEOGRAPHY (2022)
FIG 47 HOYA CORPORATION – REVENUE SPLIT BY SEGMENT (2022)
FIG 48 OLYMPUS CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 49 STERIS PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 50 ECOLAB INC. – REVENUE SPLIT BY SEGMENT AND NET SALES BY GEOGRAPHY (2022)
| ※参考情報 内視鏡再処理は、内視鏡による医療行為後に行われる重要なプロセスです。このプロセスは、内視鏡器具を感染から守り、次回の使用者や患者に対するリスクを低減させるために必要です。具体的には、内視鏡の洗浄、消毒、滅菌を通じて行われます。 内視鏡再処理には、主に三つの段階があります。第一段階は洗浄です。洗浄には、内視鏡表面の血液や体液、他の汚染物質を物理的に除去することが含まれます。この段階では、専用の洗浄剤やブラシを用いて、特に細かい部分や隙間に面している汚染物質を徹底的に取り除きます。 次に、消毒の段階があります。消毒は、微生物の数量を減少させることを目的としています。この段階では、化学的消毒剤を使用することが一般的です。消毒剤には、エタノールやグルタラール、過酸化水素などがあり、用途や器具の種類に応じて適切なものを選ぶ必要があります。 最後に、滅菌が行われます。滅菌は、微生物を完全に死滅させるプロセスであり、特に侵襲的な手技が行われる際には欠かせません。内視鏡の滅菌には、オートクレーブを使った高圧蒸気滅菌や、エチレンオキサイドガスを利用した方法、さらにはプラズマ滅菌などが採用されています。 内視鏡再処理の用途は、内視鏡検査や手術を行う医療機関において非常に幅広いです。消化器系の内視鏡検査、気道の内視鏡、泌尿器系の内視鏡など、さまざまな臓器に対する検査や治療で使用されるため、感染予防の観点からも非常に重要となります。 さらに、内視鏡再処理に関する関連技術も進化しています。洗浄機や消毒器具、滅菌システムなど、専用の機器が開発されており、品質の高い再処理を効率良く行うことが可能です。自動洗浄器は、人の手で行うことが難しい部分の洗浄を自動で実施でき、均一な洗浄力を提供します。また、消毒の際には、リアルタイムで効果を測定するセンサー技術も進化しており、より安全な環境を確保するために活用されています。 さらに、教育や訓練も重要な側面です。医療従事者に対して、内視鏡再処理の正しい方法や手順を理解させるための研修は不可欠です。適切な技術と知識があることで、再処理の効果が向上し、感染のリスクを大幅に減少させることができます。 最後に、内視鏡再処理においては、法律やガイドラインに従うことも求められます。各国の公的機関や専門団体が策定した基準に基づき、安全で効果的な処理を行うことが、患者や医療従事者の健康を守るためには欠かせません。 このように、内視鏡再処理は多面的なアプローチが求められる重要な医療プロセスです。正確で一貫した手順を守ることで、内視鏡検査や治療に伴うリスクを最小化することが可能になります。したがって、医療現場においては継続的な改善と技術の更新が必要不可欠です。内視鏡再処理の適切な実施が、患者の安全を保障し、医療の質を向上させる基盤となります。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer


